M. Treur

412 total citations
32 papers, 318 citations indexed

About

M. Treur is a scholar working on Hematology, Economics and Econometrics and Oncology. According to data from OpenAlex, M. Treur has authored 32 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Economics and Econometrics and 7 papers in Oncology. Recurrent topics in M. Treur's work include Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). M. Treur is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). M. Treur collaborates with scholars based in United Kingdom, Germany and Belgium. M. Treur's co-authors include M. Charokopou, Krystallia Pantiri, Floortje van Nooten, Malcolm Stoker, Bart Heeg, Marc Botteman, Ben van Hout, Ashish V. Joshi, Frank de Charro and Hans‐Jürgen Möller and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

M. Treur

29 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Treur United Kingdom	11	71	64	64	49	39	32	318
Klaus Krueger Germany	9	64 0.9×	112 1.8×	12 0.2×	28 0.6×	14 0.4×	21	565
Kelly McQuarrie United States	13	34 0.5×	43 0.7×	46 0.7×	9 0.2×	65 1.7×	33	634
Adeel Nasir United States	4	35 0.5×	46 0.7×	9 0.1×	11 0.2×	40 1.0×	6	428
Jesse Fishman United States	10	23 0.3×	39 0.6×	14 0.2×	43 0.9×	119 3.1×	50	405
Roni Sharon Israel	12	70 1.0×	75 1.2×	15 0.2×	18 0.4×	81 2.1×	49	335
Valeria Fadda Italy	9	8 0.1×	23 0.4×	35 0.5×	14 0.3×	60 1.5×	44	264
Shilpa Jain India	8	18 0.3×	32 0.5×	7 0.1×	27 0.6×	13 0.3×	28	262
Miranda Pans Belgium	10	43 0.6×	24 0.4×	47 0.7×	30 0.6×	244 6.3×	10	493
Ann Brownfield United Kingdom	10	15 0.2×	100 1.6×	9 0.1×	6 0.1×	47 1.2×	12	460
Rosemarie Neuner United States	10	47 0.7×	41 0.6×	13 0.2×	6 0.1×	26 0.7×	13	412

Countries citing papers authored by M. Treur

Since Specialization

Citations

This map shows the geographic impact of M. Treur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Treur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Treur more than expected).

Fields of papers citing papers by M. Treur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Treur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Treur. The network helps show where M. Treur may publish in the future.

Co-authorship network of co-authors of M. Treur

This figure shows the co-authorship network connecting the top 25 collaborators of M. Treur. A scholar is included among the top collaborators of M. Treur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Treur. M. Treur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuan, et al.. (2024). COST-EFFECTIVENESS ANALYSIS OF MIRIKIZUMAB VERSUS USTEKINUMAB IN ADVANCED THERAPY EXPERIENCED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE US. Gastroenterology. 166(3). S61–S62. 1 indexed citations

Labbé, Antoine, et al.. (2021). A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France. PLoS ONE. 16(6). e0252130–e0252130. 18 indexed citations

Hájek, Roman, Jiří Jarkovský, Vladimír Maisnar, et al.. (2018). Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies. Clinical Lymphoma Myeloma & Leukemia. 18(6). e219–e240. 18 indexed citations

Hájek, Roman, et al.. (2016). Long-Term Outcomes and Treatment Patterns in Patients with Symptomatic Multiple Myeloma in the Real-World Setting: A Retrospective Analysis of the Czech Rmg Registry. Value in Health. 19(3). A158–A158. 3 indexed citations

Hájek, Roman, Jiří Jarkovský, Walter Bouwmeester, et al.. (2016). Exploration of Survival Stratification of Patients with Multiple Myeloma after First Relapse Using Real World Data. Blood. 128(22). 2417–2417. 1 indexed citations

Charokopou, M., et al.. (2015). A Systematic Literature Review And Network Meta-Analysis of Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for The Treatment of Painful Diabetic Peripheral Neuropathy. Value in Health. 18(7). A659–A659. 2 indexed citations

Palla, Ilaria, et al.. (2015). Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis. PLoS ONE. 10(10). e0140843–e0140843. 22 indexed citations

Sapin, Christophe, et al.. (2015). Pharmacoeconomic Evaluation of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in the UK: Findings From Qualify. Value in Health. 18(7). A410–A411. 2 indexed citations

Treur, M., et al.. (2015). Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan. Journal of Medical Economics. 18(7). 502–511. 13 indexed citations

10.

Treur, M., et al.. (2015). A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service. Journal of Medical Economics. 18(10). 838–849. 14 indexed citations

11.

Heeg, Bart, Michel van Agthoven, Johan Liwing, et al.. (2014). Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT). Value in Health. 17(7). A617–A618. 2 indexed citations

12.

Chuang, Ling‐Hsiang, M. Treur, Bart Heeg, Ben van Hout, & Anna Filonenko. (2013). The use and impact of value of information analysis in decision-making. Value in Health. 16(3). A30–A30. 1 indexed citations

13.

Şaylan, Mete, et al.. (2013). Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach. Value in Health Regional Issues. 2(2). 171–180. 8 indexed citations

14.

Rosiñol, Laura, Joris Diels, Juan José Lahuerta, et al.. (2013). Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany. Value in Health. 16(7). A409–A410. 1 indexed citations

15.

Lee, Richard K., et al.. (2012). Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder. Journal of Medical Economics. 15(3). 586–600. 7 indexed citations

16.

Ji, Xinyi, et al.. (2012). PRM68 Comparative Computation Speed of Excel, Visual Basic for Applications, R, and Java in Execution of a Microsimulation Model With Probabilistic Sensitivity Analysis. Value in Health. 15(7). A472–A472. 1 indexed citations

17.

Treur, M., Enrique Baca, Julio Bobes, et al.. (2012). The cost-effectiveness of paliperidone extended release in Spain. Journal of Medical Economics. 15(sup1). 26–34. 16 indexed citations

18.

Heisen, Marieke, et al.. (2012). Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing–remitting multiple sclerosis in The Netherlands. Journal of Medical Economics. 15(6). 1149–1158. 8 indexed citations

19.

Heeg, Bart, Michel van Agthoven, Johan Liwing, et al.. (2010). Optimal Treatment Sequencing In Multiple Myeloma: An Exploratory Modeling Approach. Blood. 116(21). 3046–3046. 4 indexed citations

20.

Treur, M., Bart Heeg, Hans‐Jürgen Möller, A Schmeding, & Ben van Hout. (2009). A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. BMC Health Services Research. 9(1). 32–32. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact